Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years

Cem Akin, Vito Sabato, Jason Gotlib, Jens Panse, Iván Álvarez-Twose, Deepti H. Radia, Cristina Bulai Livideanu, Joseph Jurcic, Hanneke Oude Elberink, Paul Van Daele, Sonia Cerquozzi, Ingunn Dybedal, Andreas Reiter, Thanai Pongdee, Stéphane Barete, Celalettin Ustun, Philippe Schafhausen, Peter Vadas, Prithviraj Bose, Daniel J. DeAngelo, Lindsay Rein, Pankit Vachhani, Massimo Triggiani, Patrizia Bonadonna, Karin Hartmann, Sigurd Broesby-Olsen, Mattias Mattsson, Tracy I. George, William Shomali, Matthew Giannetti, Frank Siebenhaar, Hui-Min Lin, Ilda Bidollari, Benjamin Lampson, Janet Hong, Ashley Doyle, Tsewang Tashi, Mariana Castells

Open source

DOI: 10.1016/j.jaci.2026.04.001
Published: 2026-08
Container: Journal of Allergy and Clinical Immunology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jaci.2026.04.001,
  title = {Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years},
  author = {Cem Akin and Vito Sabato and Jason Gotlib and Jens Panse and Iván Álvarez-Twose and Deepti H. Radia and Cristina Bulai Livideanu and Joseph Jurcic and Hanneke Oude Elberink and Paul Van Daele and Sonia Cerquozzi and Ingunn Dybedal and Andreas Reiter and Thanai Pongdee and Stéphane Barete and Celalettin Ustun and Philippe Schafhausen and Peter Vadas and Prithviraj Bose and Daniel J. DeAngelo and Lindsay Rein and Pankit Vachhani and Massimo Triggiani and Patrizia Bonadonna and Karin Hartmann and Sigurd Broesby-Olsen and Mattias Mattsson and Tracy I. George and William Shomali and Matthew Giannetti and Frank Siebenhaar and Hui-Min Lin and Ilda Bidollari and Benjamin Lampson and Janet Hong and Ashley Doyle and Tsewang Tashi and Mariana Castells},
  year = {2026},
  journal = {Journal of Allergy and Clinical Immunology},
  doi = {10.1016/j.jaci.2026.04.001},
  url = {https://doi.org/10.1016/j.jaci.2026.04.001}
}

RIS

TY  - JOUR
TI  - Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years
AU  - Cem Akin
AU  - Vito Sabato
AU  - Jason Gotlib
AU  - Jens Panse
AU  - Iván Álvarez-Twose
AU  - Deepti H. Radia
AU  - Cristina Bulai Livideanu
AU  - Joseph Jurcic
AU  - Hanneke Oude Elberink
AU  - Paul Van Daele
AU  - Sonia Cerquozzi
AU  - Ingunn Dybedal
AU  - Andreas Reiter
AU  - Thanai Pongdee
AU  - Stéphane Barete
AU  - Celalettin Ustun
AU  - Philippe Schafhausen
AU  - Peter Vadas
AU  - Prithviraj Bose
AU  - Daniel J. DeAngelo
AU  - Lindsay Rein
AU  - Pankit Vachhani
AU  - Massimo Triggiani
AU  - Patrizia Bonadonna
AU  - Karin Hartmann
AU  - Sigurd Broesby-Olsen
AU  - Mattias Mattsson
AU  - Tracy I. George
AU  - William Shomali
AU  - Matthew Giannetti
AU  - Frank Siebenhaar
AU  - Hui-Min Lin
AU  - Ilda Bidollari
AU  - Benjamin Lampson
AU  - Janet Hong
AU  - Ashley Doyle
AU  - Tsewang Tashi
AU  - Mariana Castells
PY  - 2026
JO  - Journal of Allergy and Clinical Immunology
DO  - 10.1016/j.jaci.2026.04.001
UR  - https://doi.org/10.1016/j.jaci.2026.04.001
ER  -

APA

Akin, C., Sabato, V., Gotlib, J., Panse, J., Álvarez-Twose, I., Radia, D. H., Livideanu, C. B., Jurcic, J., Elberink, H. O., Daele, P. V., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., Barete, S., Ustun, C., Schafhausen, P., Vadas, P., Bose, P., DeAngelo, D. J., Rein, L., Vachhani, P., Triggiani, M., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Mattsson, M., George, T. I., Shomali, W., Giannetti, M., Siebenhaar, F., Lin, H., Bidollari, I., Lampson, B., Hong, J., Doyle, A., Tashi, T., & Castells, M. (2026). Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.04.001

Source records

crossref · retrieved 2026-09-26T08:43:45.302Z